Detalles de la búsqueda
1.
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors.
Int J Gynecol Cancer
; 34(4): 559-565, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38242547
2.
Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10.
Br J Cancer
; 128(2): 255-265, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482193
3.
Effect of BMI change on recurrence risk in patients with endometrial cancer.
Int J Gynecol Cancer
; 33(5): 713-718, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068853
4.
Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer.
Int J Gynecol Cancer
; 33(11): 1695-1701, 2023 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657818
5.
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(4): 465-478, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35298906
6.
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial.
Gynecol Oncol
; 166(3): 494-502, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35851489
7.
Brain metastases in patients with ovarian cancer.
Acta Oncol
; 61(6): 757-763, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35485453
8.
Weekly Carboplatin and Paclitaxel: A Retrospective Comparison with the Three-Weekly Schedule in First-Line Treatment of Ovarian Cancer.
Oncologist
; 26(1): 30-39, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32657524
9.
Rapid Implementation of Telemedicine During the COVID-19 Pandemic: Perspectives and Preferences of Patients with Cancer.
Oncologist
; 26(4): e679-e685, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453121
10.
Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.
Reprod Biol Endocrinol
; 19(1): 153, 2021 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34620184
11.
Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.
Gynecol Oncol
; 162(3): 715-719, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34172288
12.
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.
Int J Gynecol Cancer
; 31(12): 1589-1594, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34593565
13.
Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants.
Breast Cancer Res Treat
; 181(2): 445-453, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303989
14.
Early intervention with pulse dye and CO2 ablative fractional lasers to improve cutaneous scarring post-lumpectomy: a randomized controlled trial on the impact of intervention on final cosmesis.
Lasers Med Sci
; 34(9): 1881-1887, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31025209
15.
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
Br J Cancer
; 119(9): 1075-1085, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30353045
16.
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
Lancet Oncol
; 17(11): 1579-1589, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27617661
17.
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.
Cancer
; 122(12): 1844-52, 2016 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27062051
18.
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.
Br J Cancer
; 115(11): 1313-1320, 2016 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27824811
19.
Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel.
Breast Cancer Res Treat
; 155(1): 133-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26687385
20.
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
N Engl J Med
; 366(15): 1382-92, 2012 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22452356